Industry Leading Insights

Peer-generated best practices, guidance documents, and session highlights


Why LinkedIn Matters

Frank Dolan spoke with Joe Mullings for this edition of the ARSENAL Leader Lab series. As CEO of the Mullings Group Companies and Chief Vision Officer for MRINetwork, Mullings had extensive knowledge to offer.

Read More »
Teamwork of the doctors

5 Benefits of Community Building in Life Science

The life science industry often views community engagement in healthcare as an external concern—a matter of marketing, outreach, and education. However, building a community is about reducing the gap between complex medical concepts and customers, with healthcare being the obvious connector.

Read More »
Business interview

The Two Questions You Need To Ask During an Interview

As part of the ARSENAL Leader Lab, Frank Dolan set out to find the answer by speaking with Joe Mullings, CEO of the Mullings Group Companies and Chief Vision Officer for MRINetwork. Below, you’ll learn about the two questions you should be prepared to ask your interviewer. We hope this helps you during your job search.

Read More »
Patient Medical Files

Why Patient Marketing Matters

They go online to ask for opinions regarding their doctor’s advice. Clearly, patient marketing is more important than ever before. To help discuss what the industry needs to be aware of going forward, Frank Dolan sat down with Paul Murasko, Head of Digital Customer Interaction for Ipsen North America.

Read More »
Doctor in conversation with pharmaceutical representative

How New Personal Promotion Can Help Grow Your Pharmaceutical Brands

For many years now, the pharmaceutical industry has used the term “Non-Personal Promotion” to refer to sales and marketing techniques not done face-to-face (i.e. digital marketing efforts). Paul Murasko is unsatisfied with calling this form of promotion ‘non-personal’, though, because “you can start using data to properly send messaging at the right time, at the right place, through the right channel.”

Read More »
Pharmaceuticals pills medicine

Differentiating Your Product for Payers

Getting on the formulary is more difficult than ever before, given the number of new, high-cost drugs that are entering the market. That’s one of the reasons why Frank Dolan sat down with Steve O’Malley, Executive Vice President of Market Access at Two Labs, as part of the Life Science Leader Lab series.

Read More »